BioCentury | Apr 10, 2019
Distillery Therapeutics

Inhibiting a MYLK splice variant for IBD and colitis

...models of Crohn's disease or other intestinal diseases associated with loss of barrier function. TARGET/MARKER/PATHWAY: Myosin light chain...
...and Harvard Medical School, Boston, Mass. e-mail: Sandi Wong Brigham and Women's Hospital Harvard Medical School University of Chicago Myosin light chain...
BioCentury | Nov 2, 2016
Distillery Therapeutics


...lung. Next steps could include testing the antibodies in additional models of asthma. TARGET/MARKER/PATHWAY: CD69; myosin light chain...
...doi:10.1126/sciimmunol.aaf9154 CONTACT: Toshinori Nakayama, Chiba University, Chiba, Japan email: Hongjiang Li Chiba University CD69 Myosin light chain 12A (MYL12A) Myosin light chain 12B (MYL12B) Myosin light chain...
BioCentury | Apr 14, 2015
Politics & Policy

Regulators support C-Path's skeletal muscle biomarkers

...the Predictive Safety Testing Consortium (PSTC) of the Critical Path Institute (C-Path). Elevated levels of myosin light chain...
BioCentury | Dec 4, 2014
Tools & Techniques

Roche's heart for diabetes

...integrity. The selected clones had higher levels of several contractile markers than immature cells, including myosin light chain...
BioCentury | Nov 25, 2013
Clinical News

Neuroptis preclinical data

...Neuroptis plans to start Phase I/II testing with the eye drop formulation of ML7, a myosin light chain...
BioCentury | Nov 11, 2010
Distillery Therapeutics

Indication: Infectious disease

...Publication and contact information Infectious disease Herpes simplex virus (HSV) Myosin heavy chain 9 (MYH9); myosin light chain...
BioCentury | May 5, 2003
Company News

Northwestern University other research news

...p<0.001), and showed enhanced survival during subsequent mechanical ventilation (p=0.001). The researchers also discovered a myosin light chain...
...controls in the same model of ALI. Northwestern University , Chicago, Ill., et al. Product: Myosin light chain...
BioCentury | Nov 1, 1993
Clinical News

Spectral Diagnostics regulatory update

Spectral Diagnostics Inc. (DIAGF) DIAGF received notice of allowance for a U.S. patent covering the method of use for a diagnostic kit for the early and rapid diagnosis of chest pain. The kit detects the...
Items per page:
1 - 8 of 8